期刊文献+

烧伤病区绿脓杆菌分布特征及耐药性的变化 被引量:4

Distribution and changes in drug-resistance of pseudomonas aerugionosa in a burn unit
下载PDF
导出
摘要 目的 分析烧伤病区绿脓杆菌的分布特征及耐药性的变化趋势,以期为临床预防和治疗绿脓杆菌感染提供依据。方法 用常规方法对我院烧伤科临床标本中分离出来的绿脓杆菌相关资料进行统计分析。结果 绿脓杆菌在烧伤病区病原菌中的构成比有逐渐下降的趋势,但至2000年仍是构成比最高的革兰阴性病原菌。绿脓杆菌感染在春季的分布相对较少,年龄分布在20~30岁和50~60岁形成高点。绿脓杆菌对多数抗生素的耐药高峰出现在1997~1998年,而后逐渐下降,但对头孢噻肟钠和头孢曲松钠的耐药率近年有大幅度提高。结论 绿脓杆菌是烧伤感染主要的病原菌,也是烧伤病人抗感染治疗以及病区防止交叉感染等预防工作的重点,故应根据绿脓杆菌的分布特征及其耐药性的变化进行病区的消毒灭菌工作。 Objective To investigate the distribution and change in drug-resistance of P. aeruginosa in a burn unit in order to provide basis for the treatment and prevention of P. aeruginosa infection. Methods The data of ECL and KPN isolated from our burn unit in a 6-year period were analyzed in terms of years, seasons, ages and change in drug-resistance. Results The constituent ratio of P. aeruginosa was gradually decreased in the pathogens in burn unit, but it still ranked the first in Gram negative pathogens of the year 2000. P. aeruginosa infection was comparatively less encountered in Spring; it was prevalent in the paitents aged 20-30 and 50-60 years. The resistance of P. aeruginosa against the most antibiotics reached its peak during the period of 1997 to 1998 and then decreased gradually, but its resistance against Cefetaxime and Ceftriazone increased markedly in recent years. Conclusions Pseudomonas aerugionosa was the major pathogen for burn infection. This should be regarded as the key issue in the anti-infective treament of burn patients and prevention against cross infection in burn unit. Sterilization should be based on the distribution characters and changes in drug-resistance of P. aeruginosa in burn unit.
机构地区 解放军
出处 《北京军区医药》 2001年第6期388-389,共2页
关键词 烧伤 绿脓杆菌 抗生素类 耐药性 交叉感染 Burn Pseudomonas aerugionosa Antibiotics Drug-resistance
  • 相关文献

参考文献3

二级参考文献13

  • 1金丽华,张民权.烧伤创面中多元耐药菌株的发生率[J].浙江医学,1995,17(5):315-316. 被引量:3
  • 2Performance Standards for Antimicrobial Susceptibility Testing;Ninth Informational Supplement.
  • 3ry Standards.For Use with M2 - A6 - Disk Diffnsion,1999(19).
  • 4Jarlier V;Nicolas MH;Founrier G.Extended brond - spectrum beta- lactamases conferring transferable resistance to newer betalactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns,1998.
  • 5Itokazu GS;Quinn JP;Bell - Dixon C.Antimicrobial resistance rates among aerobic gram - negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program,1996.
  • 6Livermore DM;Yuan M.Antibiotic resistance of extendedspectrumβ - lactamases amongst Klebsiella spp. From intensive care units in Europe[J],1996.
  • 7缪竞智;张秀珍;胡云建.替卡西林-克拉维酸钾临床应用与评价,2000.
  • 8Osano E;Arakawa Y;Wacharotayankun R.Molecular charaterization of an enterobacterial metallo - β- lactamases found in a clinical isolate of Serratia marcescens that shows Imipenem resista nce,1994.
  • 9许锦民,苏丹虹.大肠埃希菌和克雷伯菌属产超广谱β-内酰胺酶的检测[J].中华医学检验杂志,1998,21(6):373-373. 被引量:64
  • 10孙长贵,陈汉美,颜秉兴,杨琳.评价三种筛选方法检测超广谱β-内酰胺酶及其临床应用[J].中华医学检验杂志,1999,22(4):228-231. 被引量:158

共引文献53

同被引文献2

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部